Business
Oncothyreon to present at Rodman & Renshaw Annual Global Investment Conference
SEATTLE, Nov. 4 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specia...
About this update from Cascade Copper Corp.
[{"type":"text","content":"\n\n\n\nSEATTLE, Nov. 4 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a\nbiotechnology company specializing in the development of innovative\ntherapeutic products for the treatment of cancer, today announced that Robert\nKirkman, M.D., President and Chief Executive Officer, is scheduled to present\nat the Rodman & Renshaw Annual Global Investment Conference in New York City\non Tuesday, November 11, 2008 at 11:35 a.m. E.T.\n\n\nA live and archived webcast of Dr. Kirkman's presentation can be accessed\nat www.oncothyreon.com under the "News & Events" section.\n\n\nAbout Oncothyreon\n\n\nOncothyreon is a biotechnology company specializing in the development of\ninnovative therapeutic products for the treatment of cancer. Oncothyreon's\ngoal is to develop and commercialize novel synthetic vaccines and targeted\nsmall molecules that have the potential to improve the lives and outcomes of\ncancer patients. For more information, visit www.oncothyreon.com.\n\n\n","length":1037,"tagName":"div"}]